RESUMO
We have investigated the ability of ruthenium red, an inorganic dye with Ca2+ entry-blocking properties and a selective antagonist of capsaicin, and of indomethacin, a cyclooxygenase inhibitor, to inhibit bronchial smooth muscle responses evoked by toluene diisocyanate in guinea pigs. Previous exposure of isolated guinea pig bronchi to ruthenium red significantly decreased the response produced by toluene diisocyanate. Further, the response to toluene diisocyanate was significantly decreased by pretreatment with indomethacin. These findings provide evidence that toluene diisocyanate-induced contractions of guinea pig bronchi are produced indirectly by generation of a prostanoid that activates capsaicin-sensitive afferents via a ruthenium red-sensitive mechanism.
Assuntos
Indometacina/farmacologia , Contração Muscular/efeitos dos fármacos , Músculo Liso/fisiologia , Rutênio Vermelho/farmacologia , Tolueno 2,4-Di-Isocianato/farmacologia , Animais , Brônquios , Cobaias , Masculino , Músculo Liso/efeitos dos fármacos , Tolueno 2,4-Di-Isocianato/antagonistas & inibidoresRESUMO
Toluene diisocyanate (TDI)-induced asthma is a frequent occupational airway disease. To determine whether a calibrated dosage of oral slow-release theophylline inhibits asthmatic reactions and the associated increase of airway responsiveness to methacholine induced by TDI, we examined six asthmatic subjects who developed a late or a dual asthmatic reaction after TDI inhalation challenge. We administered oral slow-release theophylline or placebo to each subject for 7 days according to a double-blind, randomized, cross-over study design. When the subjects received a placebo, TDI caused a late or a dual asthmatic reaction. When the subjects received theophylline. TDI caused significantly reduced late asthmatic reactions. Mean serum theophylline concentrations were within the therapeutic range. Theophylline neither modified the baseline airway responsiveness to methacholine, nor the increase of airway responsiveness to methacholine induced by TDI. These results suggest that slow-release theophylline may improve TDI-induced late asthmatic reactions, but it does not change the baseline airway responsiveness to methacholine and the increase of airway responsiveness to methacholine induced by TDI.
Assuntos
Asma/tratamento farmacológico , Teofilina/uso terapêutico , Tolueno 2,4-Di-Isocianato/antagonistas & inibidores , Administração por Inalação , Administração Oral , Análise de Variância , Asma/induzido quimicamente , Testes de Provocação Brônquica , Método Duplo-Cego , Humanos , Placebos , Teofilina/administração & dosagem , Teofilina/sangueRESUMO
We have investigated the ability of compound 48/80 and of histamine H1 and H2 receptor antagonists to inhibit toluene diisocyanate-induced contractions in isolated guinea-pig bronchi. Compound 48/80 (100 micrograms/ml) significantly inhibited toluene diisocyanate-induced contractions. By contrast, the two histamine H1 and H2 receptor antagonists, chlorpheniramine (10 microM) and cimetidine, (10 microM) did not affect toluene diisocyanate-induced contractions, but significantly inhibited contractions induced by exogenously applied histamine (100 microM) and by 48/80. We investigated which mechanisms 48/80 used to inhibit toluene diisocyanate-induced contractions, paying particular attention to the possible involvement of capsaicin-sensitive primary afferents. In vitro capsaicin desensitization (10 microM for 30 min followed by washing) significantly reduced compound 48/80-induced contractions. A capsaicin-resistant component of contraction was also evident. Ruthenium red (3 microM), an inorganic dye which acts as a selective functional antagonist of capsaicin, did not affect 48/80-induced contraction. MEN 10,207 (Tyr5,D-Trp6,8,9,Arg10)-neurokinin A (4-10) (3 microM) a selective antagonist of NK2-tachykinin receptors significantly reduced 48/80-induced contractions. These results show that compound 48/80 inhibits toluene diisocyanate-induced contractions in isolated guinea-pig bronchi. It is likely that two mechanisms are involved in the inhibition: (1) the release of mediators other than histamine by mast cells, (2) an effect of 48/80 on sensory nerves.
Assuntos
Broncoconstrição/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Tolueno 2,4-Di-Isocianato/antagonistas & inibidores , p-Metoxi-N-metilfenetilamina/farmacologia , Animais , Capsaicina/farmacologia , Degranulação Celular/efeitos dos fármacos , Glicopeptídeos/farmacologia , Cobaias , Antagonistas dos Receptores Histamínicos H1/farmacologia , Antagonistas dos Receptores H2 da Histamina/farmacologia , Técnicas In Vitro , Masculino , Mastócitos/efeitos dos fármacos , Mastócitos/ultraestrutura , Contração Muscular/efeitos dos fármacos , Neprilisina/antagonistas & inibidores , Neurocinina A/análogos & derivados , Neurocinina A/farmacologia , Fragmentos de Peptídeos/farmacologia , Rutênio Vermelho/farmacologia , Tolueno 2,4-Di-Isocianato/farmacologiaRESUMO
In order to determine whether treatment with ketotifen inhibits asthmatic reactions induced by toluene di-isocyanate (TDI), we studied six sensitized subjects with previously demonstrated dual or late asthmatic reaction after inhalation challenge with TDI. Ketotifen (1 mg b.i.d., orally) or placebo was administered for 7 days to the examined subjects, according to a double-blind, cross-over, placebo-controlled study design. When the subjects were treated with either ketotifen or placebo, FEV1 markedly decreased after exposure to TDI. These results suggest that the anti-asthmatic agent ketotifen is not effective in TDI-induced asthma and suggest that it should not be used in the prophylaxis of asthmatic reactions induced by TDI in sensitized subjects.
Assuntos
Asma/prevenção & controle , Cianatos/antagonistas & inibidores , Cetotifeno/farmacologia , Tolueno 2,4-Di-Isocianato/antagonistas & inibidores , Asma/induzido quimicamente , Método Duplo-Cego , Volume Expiratório Forçado , Humanos , Hipersensibilidade Tardia , Imunização , Cetotifeno/administração & dosagem , Cloreto de Metacolina , Compostos de Metacolina/imunologia , Distribuição Aleatória , Tolueno 2,4-Di-Isocianato/efeitos adversosRESUMO
To determine whether early and/or late asthmatic responses induced by toluene diisocyanate (TDI) are caused by a reflex mechanism involving stimulation of muscarinic receptors, we studied the effect of the muscarinic antagonist atropine on early and late airway response induced by TDI. A preliminary study was conducted in asthmatics to assess whether the selected dose of atropine provided adequate muscarinic blockade. On different days we measured the provocation dose (in milligrams) of carbachol causing a 15% decrease in FEV1 (PD15FEV1) without and with atropine premedication (0.008 or 0.012 mg/kg subcutaneous atropine 30 or 90 min before carbachol challenge test). We found that 0.008 to 0.012 mg/kg subcutaneous atropine increased the PD15FEV1 carbachol by 6- to 10-fold, inducing a consistent and prolonged decrease in nonspecific bronchial hyperresponsiveness to cholinergic agent. Then we examined 10 subjects with a history of sensitization to TDI in 2 sets of experiments. In the first set of experiments, we studied the subjects before and after exposure to TDI (0.04 ppm; 30 min) after no treatment. In the second set of experiments, carried out 1 to 2 wk later, we repeated the same procedure after treatment with atropine (0.008 to 0.012 mg/kg atropine sulfate administered subcutaneously 30 min before TDI challenge, and then at 90-min intervals after TDI exposure); all patients showed symptoms of atropine effect (dryness of mouth, cycloplegia, increased heart rate).(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Resistência das Vias Respiratórias/efeitos dos fármacos , Asma/fisiopatologia , Atropina/farmacologia , Cianatos/antagonistas & inibidores , Tolueno 2,4-Di-Isocianato/antagonistas & inibidores , Administração por Inalação , Adulto , Asma/induzido quimicamente , Carbacol/antagonistas & inibidores , Feminino , Volume Expiratório Forçado , Humanos , Masculino , Pessoa de Meia-Idade , Doenças Profissionais/induzido quimicamente , Doenças Profissionais/fisiopatologia , Tolueno 2,4-Di-Isocianato/efeitos adversosRESUMO
In order to evaluate the effect of nifedipine, a calcium channel blocker, upon specific bronchial responses to isocyanates, 5 subjects with occupational asthma due to TDI were examined. Each subject was exposed to an atmosphere containing 0.01 ppm of TDI in an inhalation chamber for 15 minutes; the test was repeated on a different day 45 minutes after administration of placebo or nifedipine (20 mg sublingually) in a random fashion. Our data show an effectiveness of nifedipine at the above mentioned dose in preventing the responses arising immediately or within one hour after the exposure (cases n. 1, 2, 3, 4, 5). For preventing late responses it was necessary to repeat the administration of nifedipine (10 mg sublingually) 2 hours after the exposure (cases n. 4 and n. 5). The mechanism by which nifedipine prevents bronchial responses to isocyanates has not been elucidated.
Assuntos
Asma/prevenção & controle , Brônquios/efeitos dos fármacos , Cianatos/antagonistas & inibidores , Nifedipino/farmacologia , Doenças Profissionais/prevenção & controle , Tolueno 2,4-Di-Isocianato/antagonistas & inibidores , Adulto , Asma/induzido quimicamente , Testes de Provocação Brônquica , Ensaios Clínicos como Assunto , Constrição Patológica , Humanos , Masculino , Nifedipino/uso terapêutico , Doenças Profissionais/induzido quimicamente , Distribuição Aleatória , Tolueno 2,4-Di-Isocianato/metabolismoRESUMO
This study was designed to evaluate the mechanism of action of toluene diisocyanate (TDI) and the role of endogenous neutral endopeptidase in modulating in vitro contractile responses to TDI in guinea pigs. TDI (0.01-1 mM) produced a concentration-dependent contraction of the guinea pig main bronchi. Sensory nerve desensitization with capsaicin greatly reduced and in some cases almost abolished TDI-induced contractions. The neutral endopeptidase inhibitor phosphoramidon significantly increased the contractile response to TDI. Pretreatment with the substance P antagonist (D-Arg1,D-Pro2,D-Trp7,9,Leu11)-substance P greatly reduced TDI-induced contractions. These results suggest that TDI activates the "efferent" function of capsaicin-sensitive sensory nerves and that neutral endopeptidase may play a role in modulating the response in guinea pigs.
Assuntos
Capsaicina/farmacologia , Contração Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Neurônios Aferentes/efeitos dos fármacos , Tolueno 2,4-Di-Isocianato/farmacologia , Animais , Antibacterianos/farmacologia , Brônquios/efeitos dos fármacos , Glicopeptídeos/farmacologia , Cobaias , Masculino , Substância P/farmacologia , Tolueno 2,4-Di-Isocianato/antagonistas & inibidoresRESUMO
Para determinar se o tratamento com Dosauxison (dexametasona-isonicotina aerossol) ou cetotifeno inibe reaçöes asmáticas e o aumento da hiperreatividade das vias aéreas induzidos pelo diisocianato de tolueno (TDI), estudamos seis pessoas sensibilizadas que apresentavam reaçöes asmáticas duais ou retardadas à inalaçäo de TDI. Três delas eram atópicas e três näo. Foram administrados por sete dias, antes da provocaçäo com TDI (0,010-0,015 ppm por 10-30 min) e em semanas bem distanciadas uma da outra, Dosauxison (quatro puffs 2 vezes/dia, i. e., 0,5 mg 2 vezes/dia, os últimos quatro puffs 30 minutos antes da inalaçäo de TDI), ou cetotifeno (1 mg 2 vezes/dia, oral), ou placebo, de acordo com uma estrutura estatística de simples cego e placebo no controle. Quando as pessoas foram tratadas com cetotifeno ou placebo, o VEF1 diminuiu marcadamente e a hiperreatividade aumentou após exposiçäo ao TDI. Pelo contrário, quando receberam Dosauxison, a queda do VEF, após o TDI foi significativamente menor. Esses resultados sugerem que o Dosauxison aerossol é altamente efetivo na asma provocada pelo TDI